KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Stereotaxis (STXS) Long-Term Debt Issuances (2012 - 2020)

Stereotaxis (STXS) reported Long-Term Debt Issuances of -$41690.0 for Q2 2020, down 189.99% on a QoQ basis from $46328.0 in Q4 2013.

Stereotaxis (STXS) has 3 years of Long-Term Debt Issuances data on file, last reported at -$41690.0 in Q2 2020.

  • Quarterly Long-Term Debt Issuances changed N/A year-over-year to -$41690.0 in Q2 2020, while the trailing twelve-month figure through Dec 2020 was $4638.0 (changed N/A YoY) and the FY2020 annual result came in at $2.2 million, changed N/A from the prior year.
  • Long-Term Debt Issuances declined to -$41690.0 in Q2 2020 per STXS's latest filing, from $46328.0 in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at -$41690.0 in Q2 2020 and bottomed at -$41690.0 in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 46.00 Mn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 875.40 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 5.04 Mn
10 Stereotaxis 187.40 Mn 172.78 Mn 3.79 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2020 -41,690.00
Jun 30, 2020 -41,690.00
Dec 31, 2013 46,328.00
Dec 31, 2013 46,328.00
Mar 31, 2013 2.50 Mn
Mar 31, 2013 2.50 Mn
Dec 31, 2012 -5.24 Mn
Dec 31, 2012 -5.24 Mn